[Results of Nandrolone therapy (Keratyl) in lesions and diseases of the cornea (author's transl)].
The authors report on clinical experiences with the topical application of the synthetic hormone Nandrolon (Keratyl) in diseases of the cornea caused by exogenic, neurogenic, and combined exogenic-endogenic factors. In all cases a positive regenerative effect on epithelium and stroma of the cornea seemed to exist. The present results seem to allow the following range of indications: 1. injuries of the epithelial tissue; 2. ulcera of the cornea (combined with antibiotics); 3. dystrophic diseases of the cornea; 4. certain postoperative treatment after keratoplastic surgery.
D055598:Chemical Phenomena; D002621:Chemistry; D003315:Cornea / Q000601:surgery; D003316:Corneal Diseases / Q000188:drug therapy*; D003317:Corneal Dystrophies, Hereditary / Q000188:drug therapy; D065306:Corneal Injuries; D003320:Corneal Ulcer / Q000188:drug therapy; D005131:Eye Injuries / Q000188:drug therapy; D006801:Humans; D009277:Nandrolone / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000188:drug therapy
D009277:Nandrolone
Ergebnisse der Nandrolontherapie (Keratyl) bei Hornhautverletzungen und-erkrankungen.